We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Chemical Triggers Breast Cancer

By Biotechdaily staff writers
Posted on 21 Jul 2005
An estrogen-mimicking chemical has been found to be a potent trigger of breast cancer. More...


The chemical, 4-nonylphenol (4-NP), is released into the environment from plastics, cleaning materials, textiles, and some paper. The chemical has also been found in drinking water and some processed foods. It stimulates an enzyme system in the liver that increases the production of estriol, a hormone associated with breast cancer. The chemical's affinity for estrogen receptors in breast tissue is 4,000 times less than that of estrogen.

In comparing the effects of various doses of 4-NP and estrogen on mice, researchers discovered that while 4-NP stimulates estriol metabolism in the liver, it does not lead to increased levels of estriol in the bloodstream. They concluded that as well as stimulating enzymes that produce estriol, 4-NP also has a direct inhibiting effect on estriol production. In a second experiment, the researchers gave doses of 4-NP to mice genetically engineered to readily develop breast cancer. Over a 32-week period, many of these mice developed breast cancer. Those given equivalent doses of estrogen, based on the relative binding affinities of 4-NP and estradiol for their receptors, did not develop mammary cancer.

"Long term exposure to 4-nonylphenol could leave individuals at a significantly increased risk of developing breast cancer,” concluded toxicologist William Baldwin, from the University of Texas, El Paso (USA), a member of the research team. The findings were reported in the July 12, 2005, online edition of the Journal of Applied Toxicology (Wiley InterScience).


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.